chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12 Hours after receiving the Vaccine I developed shivering chills, shortly after that developing a fever that peaked at 102 along with night sweats, painful headache, dizziness, nausea when standing. These symptoms lasted for roughly for 12-18 hours after they began.
05/14/2022 That evening I felt chills, a low grade fever of 100.4, head ache and had no cough. The next morning, 05/15/2022, I took a home COVID test (I had taken a test 2 days before because I was tired, it was negative) that was positive. 05/16/2022 I let my doctor's office know, I was positive. I had a tele health with my CPN and he prescribed PAXLOVID. I began to read about the side effects of PAXLOVID and I decided not to take it and wanted to let my immune system take care of it. By the morning of 5/18/2022, I was feeling much better. I am not fully 100% yet. I tested again on 5/21/2022 and it was faintly positive.
Yellow discoloration, bruising around injection site, warm to touch in first few days of administration, slight bruising shown to pharmacist on 6/16/18.
Following both Pfizer Covid vaccinations, they have tested positive for Covid  on 3/16 1st Pfizer EH9899 12/18/2020 2nd Pfizer EL3246 1/8/2021 Ill 3/15 with vomiting x 20+ times in 24 hrs  PCR Covid test 3/16/2021 is Positive
Day of vaccine, sore arm, small bump on injection site. Experienced chills, fever, headache, body ache next day. Took ibuprofen during the day & nyquil at night.  Feb 5, Wed- 3am, getting ready for work, arm very hot and sore. Discovered a swollen red patch on injection site. Unable to lift arm all the way due to pain. Redness spreads through out the day. Took Benadryl 25mg at 5:20pm, and another at 7:20pm, redness and swelling still not subsiding.  Next day, arm is not as swollen or red but still painful to touch and hot and more itchy. Seems to be spreading slowly lower down and subsiding from the top.
Large 10 cm cellulitis surrounding injection site + tender, erythematous, warm. Treated with 1000 mg IM Ceftrioxone.
tested positive home (nose swab) and pharmacy test (nose swab); both taken on 11/2/21. Symptoms are: chills, weakness, body aches, coughing, sneezing, and denies other covid symptoms.
No adverse reaction. Patient wrote down birthday as 2/26/2003 making them 18 instead of 8/26/2003.
About 15 min ?icy hot? numb feeling hands feet, lips mouth, dizzy, difficulty thinking,   heart pounding, tongue felt big, nausea, tightness back throat that progressed down neck, paramedics reported near syncope decreased pupil& verbal response, tachycardia, red neck chest, spots on face.  On site ambulance IV meds Epi? Benadryl 50mg and o2, transferred to ER- IV meds Pepcid and solumedrol, and home 5 days oral prednisone, Benadryl, Pepcid, albuterol
100.7 FEVER DAY AFTER SHINGRIX. DEVELOPED LEFT SIDED NECK PAIN DAY AFTER THAT. NO HEADACHE.   NO COUGH, WHEEZE, OR ANGIOEDEMA.    Sore muscles left shoulder and neck have persisted.   No weakness, rash, or numbness.
Pain on the injection site; This is a spontaneous report from a contactable physician. A 47-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: not reported, expiration date: not reported) intramuscular, administered in Arm Left on 31Dec2020 09:00 (at the age of 47 years) as dose 1, single for covid-19 immunization in hospital. The patient medical history and concomitant medications were not reported. Patient had no known allergies. Patient did not had any other vaccine in four weeks. Patient was not tested covid post vaccination. Patient had no Covid prior vaccination. On 31Dec2020 16:00, the patient experienced pain on the injection site. Patient did not received any treatment. Clinical outcome of the event was reported as recovered on an unspecified date.  Follow-up attempts completed. No further information expected.
In May 2021, One afternoon I randomly started having pain in my jaw joint, that wouldn?t allow me to open my jaw fully. I made an appt with dentist and he suggested a mouth guard in which I tried for 4mths with no change. Symptoms worsen when laying head back. Dr. said it wasn?t from grinding as I have no indication of grinding and pain would be consistent on both jaw joints. He refers me to a TMJ specialist to look into further treatment options. I have an appointment on Oct 20 for initial consultation.
Less than 72 hours after receiving the Pfizer vaccine for COVID-19 I had severe joint pains in my right hand up into my right elbow and swelling of all my right fingers except my right thumb.  It took several days for the symptoms to clear and required that I take one PTO day since I couldn't type or hold a mouse.
a vial that was exposed to room temperature range for 26 hours; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (a vial that was exposed to room temperature range for 26 hours) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084j21a) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (a vial that was exposed to room temperature range for 26 hours). On 25-Jan-2022, EXPIRED PRODUCT ADMINISTERED (a vial that was exposed to room temperature range for 26 hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided. The vial was exposed to room temperature range for 26 hours.
Patient presented to the hospital with left leg pain and swelling in the groin region as well as fever.  Xrays were performed and blood clotting was diagnosed.  Symptoms started around 4/5/2019, but he did not seek immediate treatment until the condition worsened. This is a new diagnosis.  Upon discharge he was prescribed both Ciprofloxacin and Eliquis
She had the injected attenuated flu vaccine. Fever had set in along with body pain. The fever and flu symptoms escalated by Thursday. On Friday she was very tired and unable to attend college, kept throwing up. On Saturday the vomiting continued with fever and shivering bouts. She was unable to get out of bed that morning. She found that medicine prescribed for preventing vomiting did not make it stop. She threw up medications. No amount of Tylenol/ ibuprofen was working. She started taking medication that had been prescribed for headaches- Imitrex. She was given meal shakes only one of which she could keep down. The other meals consisted of chicken noodle soup. Possibly will visit the ER. I'm surprised how attenuated vaccine could cause flu.
Fall down completely to the floor; Felt extremely dizzy; Bad stomachache; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Fall down completely to the floor) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL DIHYDRATE (LISINOPRIL [LISINOPRIL DIHYDRATE]), HYDROCODONE, SIMVASTATINE and CYCLOBENZAPRINE for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced LOSS OF CONSCIOUSNESS (Fall down completely to the floor) (seriousness criterion medically significant), DIZZINESS (Felt extremely dizzy) and ABDOMINAL PAIN UPPER (Bad stomachache). On 29-Apr-2021, LOSS OF CONSCIOUSNESS (Fall down completely to the floor) had resolved. On 05-May-2021, DIZZINESS (Felt extremely dizzy) and ABDOMINAL PAIN UPPER (Bad stomachache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not applicable. Treatment for the events included antacid.  Company Comment : Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to US-MODERNATX, INC.-MOD-2021-128874 (E2B Linked Report). This case was linked to MOD-2021-128772 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. US-MODERNATX, INC.-MOD-2021-128874:Husband 2nd dose
About a 10 days after my second COVID vaccine I had sudden heart palpatations and chest pain that felt like I was having a heart attack. This continued at random times for about 3-4 weeks. Sometimes during the day, sometimes at night, sometimes while active, sometimes while at rest. About 4 weeks later this dissappeared and has not returned.
Localized swelling and erythema to vaccination site. Painful to touch it is firm, area is hot. Swelling has increased from day 2 to day 3. Subcutaneous injection to rt arm at 0822am 8/28/17. Noticed swelling and pain on 8/29/17. Swelling has increased in size 8/30/17.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site itching in a female patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX (subcutaneous). On an unknown date, less than a week after receiving SHINGRIX, the patient experienced injection site itching, injection site erythema and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site itching, injection site erythema and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the injection site itching and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that the patient was presented for consult stating she had been given SHINGRIX at another pharmacy about a week before the date of reporting. The patient was given SHINGRIX subcutaneously in her left arm below her triceps, which led to inappropriate route of vaccination. The pharmacist noted that the area was red and itching and advised warm compress and BENADRYL. The pharmacist called asking about the product as he was unfamiliar with it. The pharmacist did not have any additional information.
A report was received from a health care professional on 12/10/03 concerning an unknown number of patients aged less than 4 years of age and of unknown gender who inadvertently received Fluvirin on an unknown date. On an unknown date, an unknown number of patients aged less than 4 years of age and of unknown gender inadvertently received Fluvirin. No adverse events have occurred as a result at the time of the report. There was insufficient information to determine the reporter's causality assessment.
pt returned to vaccine area 1 hr after receiving flu vaccine.Complained of funny taste in mouth,throat tightening,trouble swallowing,entire left arm sore.Pt took sips of water with Benadryl. Emergency rescue team called,pt stated she was feeling better and did not require hospitalization
Tinnitus has increased in volume times 2 over the past year; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received BNT162b2 (BNT162B2), on 04Sep2021 as dose 3 (booster), single (Lot number: FC3183) at the age of 65 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "HB controlled well" (unspecified if ongoing); "border dibeties" (unspecified if ongoing), notes: border dibeties (140 gl,6.1 a1c),; "high cholesterol controlled" (unspecified if ongoing); "Tinnitus", start date: 01Jan1960 (ongoing), notes: Tinnitus, I've had this all my life; start time: 12 :00 AM. Concomitant medication(s) included: VALSARTAN; METOPROLOL SUCCINATE. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Batch/lot number: EL9269; Anatomical location: Right arm), administration date: 02Feb2021, when the patient was 65-year-old, for Covid-19 immunization; BNT162b2 (DOSE 2, SINGLE: Batch/lot number: EN6202; Anatomical location: Right arm), administration date: 28Feb2021, when the patient was 65-year-old, for Covid-19 immunization. The following information was reported: TINNITUS (non-serious), outcome "not recovered", described as "Tinnitus has increased in volume times 2 over the past year". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of tinnitus.  Additional information: The patient was planning new booster (injection 4) in Oct2022. Patient would update if tinnitus volume increases to higher level after booster. The patient had no other vaccine in four weeks. The patient had no COVID prior vaccination and not tested post vaccination. Had no known allergies.  Follow-up attempts are completed. No further information is expected.
Tooth infection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TOOTH INFECTION (Tooth infection) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was Provided by Reporter .     On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOOTH INFECTION (Tooth infection). The patient was treated with CLINDAMYCIN at an unspecified dose and frequency. At the time of the report, TOOTH INFECTION (Tooth infection) outcome was unknown.            Reporter did not allow further contact
Red swollen area on upper arm around injection area (about 4 inches in diameter) pt said it is very painful.
16yo patient that accidentally got the 1st dose the of Moderna Covid-19 vaccine; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16yo patient that accidentally got the 1st dose the of Moderna Covid-19 vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history reported).    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16yo patient that accidentally got the 1st dose the of Moderna Covid-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16yo patient that accidentally got the 1st dose the of Moderna Covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: no new information
Per discharge summery, he experienced shortness of breath approximately 2 hours after vaccination while resting at home. He stood up and paced and felt better but worsened when he sat back down.  In the ED he was found to be in hypertensive urgency and started on labetolol 20mg and coreg 25mg, and admitted to the ICU for cardene drip for pressure of 232/110. He was weaned off the drip and remained stable with a new hypertension medication regimen and discharged home. He has a known history of hypertension.
Less than 15 minutes after vaccine I experienced frontal sensations in my brain. I also felt very dizzy and have ringing in left ear. A day after I experienced a dull headache for almost a month.
His arm to be "a little sore"; This is a spontaneous report from a contactable consumer (patient). A male patient of unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number was not reported) via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient medical history included broken arm. Concomitant medications were not reported. The patient had reported that the first injection caused his arm to be a little sore on an unspecified date. Patient wants to know if there was specific guidance on which arm to get the second dose in and second dose of the Pfizer vaccine was scheduled next week. The outcome of the event was unknown.   Follow-up attempts are completed. No further information is expected.
Administer expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patients, after the manufacture date of expiration) in a 66-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.  On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 173 doses.  The vial did not undergo any temperature excursions.  Treatment information was not provided.   This case was linked to MOD-2022-581986 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live follow up received included non significant information of secondary reporter was added.
Extremely sore arm, fever of 101, ear ache, congestion, whole body hurts and is very sensitive.
Up until the adverse reaction, I had little to no detectable symptoms. My 5 yr. old hist platelet have been approximately 170-200. On 12/15/20, I had a whitish sore on the tip of my tongue and concluded that I had accidently bit myself chewing food. The next day a similar sore appeared on the inside of my left cheek and I concluded it probably was the result action. On the evening of 12/20/20 at approximately 11:30 pm I woke up and needed to sneeze. I went into the bathroom, sneezed and because my mouth felt odd I opened wide and looked in the mirrow. My tongue and inside of my mouth was filled will dark purple blisters about 1/4 inch in diam. Following a telemed went to ER. 1,000 PLT #. DIAGNOSED W/IPT. Was given 77 mcg / My We 77kg (of Enplate) This was given to me 1/8/2020 prior to Discharge at 7PM that evening with PLT count at 30. 1/11/2021 - PLT count 33 1/13/2021 - PLT count 111,000!!! My doctor will now begin weaning me off steroids (prednisone) and N Plate to determine if platelet growth due to medications or my Body's renewal of natural platelet growth. While I'm not out of the woods yet, I think I can see light through trees. Additional info: My Family has a history of Autoimmune Diseases. 1) My mother died as a result of being inflicted with polyanyositis. 2) My 63 yoa sister was diagnosed with Guillain-Barre syndrome (GBS) not related to flu vaccine she told me she did not get vac. that year about 6 years ago. She survived and is doing well. Based on all above, I'm concerned Fluzone +65 HD caused my ITP.
On April 5, 2021, developed uncontrollably high blood pressure, resulting in a  TIA and  8-day hospitalization -
The pt experienced a rash at the injection site than spread over both legs, abdomen, developed urinary infection. Not sure if UTI was related to vaccine. Fever was 103.
18y female patient was given a MENACTRA injection twice, no AE; Initial information received on 16-Sep-2020 regarding an unsolicited valid non-serious case from a other health professional.  This case involves a 18 years old female patient who was vaccinated with MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] on 16-Sep-2020 inadvertently. While, she had received her booster dose on 28-Jul-2020 (extra dose administered).  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE  for prophylactic vaccination on an unknown date.   On 28-Jul-2020, the patient received a dose of the MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot number and expiration date not reported) via unknown route in unknown administration site and on 16-Sep-2020, the patient again received a 0.5 ml booster dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6745AA and expiration date:10-Jun-2021) via intramuscular route in the right deltoid for prophylactic vaccination.  It was an actual medication error case due to extra dose administered (same day latency).  No adverse event reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Client reports pain & burning sensation to right upper arm since flu vaccination.  Severe pain started approximately 2 wks after administration.  She reports pain is better at times, then worse again.  She states it has affected her ROM to this arm, & can't lay on this side.
4/15/08 Seizure occured at bedtime. Taken to E.D., CT scan done. 5/15/08 Seizure occured at bedtime. Taken to another Hosp. EEG showed mildly abnormal brain activity. Possibly hormonal trigger. Prescribed seizure medication, Kepra. Continues to be followed medically. 8/15/08-records received-4/21/08-The EEG was performed after one episode of generalized tonic-clonic seizure on 4/8/08. Presented to ED on 5/17/08-after seizure at home, eyes rolled back, sleepy afterward. Similar episode last month during her period. 5/22/08-neurology consult exam essentially normal. Impression: generalized epilepsy.
soreness after first shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness after first shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (soreness after first shot). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN (soreness after first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-038612 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Feb-2021: Additional information received